Supply Chain Vulnerabilities Exposed by Shortages of Cancer Drugs


💊 Supply Chain Vulnerabilities Exposed by Shortages of Cancer Drugs.

Shortages of chemotherapy drugs, such as cisplatin and carboplatin, are leading to calls for strengthening the U.S. drug supply chain. The reliance on a limited number of manufacturers to produce high-demand cancer drugs has resulted in rationing of care, long-distance patient travel for treatment, and the use of riskier alternatives. The shortage, caused by factory shutdowns and quality concerns, highlights the vulnerability of the supply chain, prompting advocacy groups and lawmakers to seek solutions and expand the FDA's authority in regulating the drug supply chain.

Read more from Axois ▶

Previous
Previous

South America's Lithium Triangle Enters a New Era

Next
Next

OPEC data suggests that Saudi Arabia's decision to reduce oil output will tighten the oil market